Lilly, J&J, AbbVie and WuXi help seed a regenerative medicine upstart
The Accelerator Corporation out of Seattle is birthing a new biotech baby today called Rodeo Therapeutics, which will start out with a $5.9 million A round and an ambitious goal to develop molecules that can amp up tissue regeneration.
Rodeo is getting started with three scientific godfathers: Case Western’s Sanford Markowitz, Stanton Gerson from the National Center for Regenerative Medicine and Joseph Ready out of UT Southwestern.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.